1. Sweeney TR. A survey of compounds from the Antiradiation Drug Development Program of the US Army Medical Research Development Command. (Walter Reed Inst Res) Washington, DC: US Government Printing Office 1979; 1–851.
2. Patt HM, Tyree EB, Straube RL, et al. Cysteine protection against X irradiation. Science 1949; 110:213–214.
3. Giambarresi L, Jacobs AJ. Radioprotectants. In: Conklin JJ, Walker RI, eds. Military Radiobiology. Orlando, FL: Academic Press, 1987; 265–301.
4. Das KC, Lewis-Molock Y, White CW. Activation of NFκB and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. Am J Physiol 1995; 269: L588–L602.
5. Murley JS, Kataoka Y, Weydert CJ, et al. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat Res 2002; 158: 101–109.